Shares in Advanced Oncotherapy (AVO) have been cancelled from trading on AIM as the proton beam therapy business continues to grapple with ongoing cash flow issues and a refinancing deal that has failed to materialise. The news comes just days after the company announced yet another delay to its proposed financing transaction with a new…
Join thousands of sector professionals







©2026 All rights reserved LaingBuisson

